Ching-Ying Huang

发表

Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy

P. C. Hsieh, Yu-Che Cheng, Martin W. Nicholson, 2022, Cells.

The HER2 inhibitor lapatinib potentiates doxorubicin-induced cardiotoxicity through iNOS signaling

A. Cheng, P. C. Hsieh, Wan-Tseng Hsu, 2018, Theranostics.

Generation of induced pluripotent stem cells (IBMSi011-A) from a patient with Parkinson's disease carrying LRRK2 p.I1371V mutation.

P. C. Hsieh, Chin-Hsien Lin, Huai-En Lu, 2019, Stem cell research.

Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant.

P. C. Hsieh, Chin-Hsien Lin, Huai-En Lu, 2018, Stem cell research.

Cardio- and Neurotoxicity of Selected Anti-COVID-19 Drugs

T. Kamp, Chien-Hsiun Chen, Ying-Ta Wu, 2022, Pharmaceuticals.

Generation of a human induced pluripotent stem cell (iPSC) line (IBMS-iPSC-048-05) from a patient with ALS and parkinsonism having a hexanucleotide repeat expansion mutation in C9orf72 gene.

L. Tsai, P. C. Hsieh, Chin-Hsien Lin, 2020, Stem cell research.

Human iPSC banking: barriers and opportunities

Yueh-Ting Chiu, P. C. Hsieh, Yu-Che Cheng, 2019, Journal of Biomedical Science.

Population-based high-throughput toxicity screen of human iPSC-derived cardiomyocytes and neurons.

T. Kamp, Chien-Hsiun Chen, Joseph C. Wu, 2022, Cell reports.

Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank

S. Chiou, Ling-Hui Li, T. Kamp, 2020, Journal of biomedical science.

Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes

T. Kamp, H. Chen, D. Hwang, 2019, EBioMedicine.

Generation of IBMS-iPSC-015, -016, -017 human induced pluripotent stem cells (IBMSi013-A, IBMSi014-A, and IBMSi015-A) derived from patients with atrial fibrillation.

L. Lo, Yenn-Jiang Lin, Yu-Feng Hu, 2021, Stem cell research.

Generation of induced pluripotent stem cells from a Bardet-Biedl syndrome patient carrying a homologous BBS2 c.534 + 1G > T mutation.

P. C. Hsieh, Y. Chiu, Jia-Jung Lee, 2021, Stem cell research.

Generation of an induced pluripotent stem cell line from a 39-year-old female patient with severe-to-profound non-syndromic sensorineural hearing loss and a A1555G mutation in the mitochondrial MTRNR1 gene.

Yu-Ting Wu, Yau-Huei Wei, P. C. Hsieh, 2017, Stem cell research.

Generation of an induced pluripotent stem cell (iPSC) line from a 40-year-old patient with the A8344G mutation of mitochondrial DNA and MERRF (myoclonic epilepsy with ragged red fibers) syndrome.

Yu-Ting Wu, Yau-Huei Wei, P. C. Hsieh, 2018, Stem cell research.

Generation of novel induced pluripotent stem cell (iPSC) line from a 16-year-old sialidosis patient with NEU-1 gene mutation.

C. Tsai, W. Shyu, Shih-Ping Liu, 2018, Stem Cell Research.

Reprogramming of a human induced pluripotent stem cell (iPSC) line (IBMSi012-A) from an early-onset Parkinson's disease patient harboring a homozygous p.D331Y mutation in the PLA2G6 gene.

P. C. Hsieh, Chin-Hsien Lin, Huai-En Lu, 2019, Stem cell research.

Human iPSC banking: barriers and opportunities

Yueh-Ting Chiu, P. C. Hsieh, Yu-Che Cheng, 2019, Journal of Biomedical Science.

Copy number variant hotspots in Han Taiwanese population induced pluripotent stem cell lines - lessons from establishing the Taiwan human disease iPSC Consortium Bank

S. Chiou, Ling-Hui Li, T. Kamp, 2020, Journal of Biomedical Science.

Generation of IBMS-iPSC-021, -022, -023 human induced pluripotent stem cells (IBMSi016-A, IBMSi017-A, and IBMSi018-A) derived from patients with the ALDH2 rs671 polymorphism.

L. Lo, Yenn-Jiang Lin, Yu-Feng Hu, 2021, Stem cell research.

Combined Treatment of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes and Endothelial Cells Regenerate the Infarcted Heart in Mice and Non-Human Primates

T. Kamp, T. Hacker, Jianhua Zhang, 2023, Circulation.